219 related articles for article (PubMed ID: 33411080)
1. Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma.
Leenen S; Hermens M; de Vos van Steenwijk PJ; Bekkers RLM; van Esch EMG
Cancer Immunol Immunother; 2021 Jul; 70(7):1821-1829. PubMed ID: 33411080
[TBL] [Abstract][Full Text] [Related]
2. Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.
Suryawanshi S; Huang X; Elishaev E; Budiu RA; Zhang L; Kim S; Donnellan N; Mantia-Smaldone G; Ma T; Tseng G; Lee T; Mansuria S; Edwards RP; Vlad AM
Clin Cancer Res; 2014 Dec; 20(23):6163-74. PubMed ID: 25294912
[TBL] [Abstract][Full Text] [Related]
3. Molecular changes in endometriosis-associated ovarian clear cell carcinoma.
Worley MJ; Liu S; Hua Y; Kwok JS; Samuel A; Hou L; Shoni M; Lu S; Sandberg EM; Keryan A; Wu D; Ng SK; Kuo WP; Parra-Herran CE; Tsui SK; Welch W; Crum C; Berkowitz RS; Ng SW
Eur J Cancer; 2015 Sep; 51(13):1831-42. PubMed ID: 26059197
[TBL] [Abstract][Full Text] [Related]
4. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
[TBL] [Abstract][Full Text] [Related]
5. Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.
Gadducci A; Lanfredini N; Tana R
Gynecol Endocrinol; 2014 Sep; 30(9):612-7. PubMed ID: 24905724
[TBL] [Abstract][Full Text] [Related]
6. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.
Mandai M; Matsumura N; Baba T; Yamaguchi K; Hamanishi J; Konishi I
Cancer Lett; 2011 Nov; 310(2):129-33. PubMed ID: 21802200
[TBL] [Abstract][Full Text] [Related]
7. Discovering the Deregulated Molecular Functions Involved in Malignant Transformation of Endometriosis to Endometriosis-Associated Ovarian Carcinoma Using a Data-Driven, Function-Based Analysis.
Chang CM; Yang YP; Chuang JH; Chuang CM; Lin TW; Wang PH; Yu MH; Chang CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113136
[TBL] [Abstract][Full Text] [Related]
8. Models of endometriosis and their utility in studying progression to ovarian clear cell carcinoma.
King CM; Barbara C; Prentice A; Brenton JD; Charnock-Jones DS
J Pathol; 2016 Jan; 238(2):185-96. PubMed ID: 26456077
[TBL] [Abstract][Full Text] [Related]
9. Increased steroid receptor RNA activator protein (SRAP) accompanied by decreased estrogen receptor-beta (ER-β) levels during the malignant transformation of endometriosis associated ovarian clear cell carcinoma.
Lin K; Zhan H; Ma J; Xu K; Wu R; Zhou C; Lin J
Acta Histochem; 2014 Jun; 116(5):878-82. PubMed ID: 24704270
[TBL] [Abstract][Full Text] [Related]
10. Endometrioid carcinoma of the ovary and endometriosis: the association in postmenopausal women.
DePriest PD; Banks ER; Powell DE; van Nagell JR; Gallion HH; Puls LE; Hunter JE; Kryscio RJ; Royalty MB
Gynecol Oncol; 1992 Oct; 47(1):71-5. PubMed ID: 1427405
[TBL] [Abstract][Full Text] [Related]
11. The origin of endometriosis-associated ovarian cancer from uterine neoplastic lesions.
Garavaglia E; Sigismondi C; Ferrari S; Candiani M
Med Hypotheses; 2018 Jan; 110():80-82. PubMed ID: 29317075
[TBL] [Abstract][Full Text] [Related]
12. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
Mhawech P; Kinkel K; Vlastos G; Pelte MF
Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
[TBL] [Abstract][Full Text] [Related]
13. MiR-191 modulates malignant transformation of endometriosis through regulating TIMP3.
Dong M; Yang P; Hua F
Med Sci Monit; 2015 Mar; 21():915-20. PubMed ID: 25819812
[TBL] [Abstract][Full Text] [Related]
14. [Endometriosis and endometriosis-related ovarian neoplasms].
Totev T; Tomov S; Gorchev G
Akush Ginekol (Sofiia); 2013; 52(6):38-42. PubMed ID: 24501879
[TBL] [Abstract][Full Text] [Related]
15. Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review.
Mikhaleva LM; Davydov AI; Patsap OI; Mikhaylenko EV; Nikolenko VN; Neganova ME; Klochkov SG; Somasundaram SG; Kirkland CE; Aliev G
Adv Ther; 2020 Jun; 37(6):2580-2603. PubMed ID: 32385745
[TBL] [Abstract][Full Text] [Related]
16. Malignant transformation of ovarian endometriosis.
Nishida M; Watanabe K; Sato N; Ichikawa Y
Gynecol Obstet Invest; 2000; 50 Suppl 1():18-25. PubMed ID: 11093057
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.
Nishio N; Kido A; Kataoka M; Kuwahara R; Nakao K; Kurata Y; Matsumura N; Mandai M; Togashi K
Eur J Radiol; 2018 Aug; 105():175-181. PubMed ID: 30017276
[TBL] [Abstract][Full Text] [Related]
18. Endometriosis and ovarian cancer: thoughts on shared pathophysiology.
Ness RB
Am J Obstet Gynecol; 2003 Jul; 189(1):280-94. PubMed ID: 12861175
[TBL] [Abstract][Full Text] [Related]
19. [Clinical discussion of the relationship between endometriosis and epithelial ovarian cancer].
Zhang Y; Huang H; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):544-6. PubMed ID: 11360640
[TBL] [Abstract][Full Text] [Related]
20. Endometriosis-associated ovarian cancer: a clinicopathologic review.
Steed H; Chapman W; Laframboise S
J Obstet Gynaecol Can; 2004 Aug; 26(8):709-15. PubMed ID: 15307975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
